title: Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.
authors: Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
authors: X
authors: X
authors: Chen
authors: Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR, USA.
authors: L F
authors: LF
authors: Newell
authors: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
authors: H
authors: H
authors: Xie
authors: 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
authors: R B
authors: RB
authors: Walter
authors: 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
authors: J M
authors: JM
authors: Pagel
authors: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
authors: V K
authors: VK
authors: Sandhu
authors: 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
authors: P S
authors: PS
authors: Becker
authors: Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
authors: P C
authors: PC
authors: Hendrie
authors: Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
authors: J L
authors: JL
authors: Abkowitz
authors: 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
authors: F R
authors: FR
authors: Appelbaum
authors: 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
authors: E H
authors: EH
authors: Estey
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001752:Blast Crisis / Q000188:drug therapy* / Q000473:pathology*; D001854:Bone Marrow Cells / Q000166:cytology*; D005260:Female; D006801:Humans; D060828:Induction Chemotherapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010976:Platelet Count; D011379:Prognosis; D012074:Remission Induction
references: Leukemia. 2013 Oct;27(10):2068-72
references: 23648670
references: J Natl Compr Canc Netw. 2012 Aug;10 (8):984-1021
references: 22878824
references: Blood. 2010 Sep 30;116(13):2224-8
references: 20562328
references: Leuk Res. 2008 Oct;32(10):1505-9
references: 18405972
references: J Clin Oncol. 2003 Dec 15;21(24):4642-9
references: 14673054
references: J Clin Oncol. 2015 Apr 10;33(11):1258-64
references: 25732155
references: Blood. 2000 Jan 1;95(1):72-7
references: 10607687